Healthcare ❯ Pharmaceuticals ❯ Drug Development

Weight Loss Treatments

Clinical Trials Zepbound

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone

Explosive tirzepatide sales recalibrated investor expectations for Lilly’s long-term growth.